Company intelligence / Profile preview

Avary

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Avary is a personalized health and longevity company that provides a comprehensive platform for health optimization and disease prevention. The company integrates advanced diagnostics, including whole-body MRI, genetic testing, and continuous metabolic monitoring, with personalized clinical guidance to help individuals extend their healthspan. By leveraging data-driven insights, Avary aims to detect potential health issues early and provide actionable strategies for improving long-term wellness. Their services are designed for proactive individuals seeking a high-touch, precision medicine approach to healthcare.

Therapeutic areas: CardiovascularOncologyMetabolic DisordersOther
Modalities: DiagnosticsPersonalized MedicineDigital Health Platform
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Avary.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avary.

Explore the full profile